News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Brophy Gerard
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 19,683 shares
@ $20.28, valued at
$399.2k
|
|
| 03/06/2023 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Sold 3,914 shares
@ $25, valued at
$97.9k
|
|
| 03/01/2023 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Sold 3,059 shares
@ $25, valued at
$76.5k
|
|
| 02/27/2023 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 1,893 shares
@ $24.59, valued at
$46.5k
Granted 20,308 shares
@ $0
Paid exercise price by delivering 2,040 shares
@ $24.62, valued at
$50.2k
Granted 49,215 options to buy
@ $24.62, valued at
$1.2M
|
|
| 02/22/2023 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 3,072 shares
@ $24.54, valued at
$75.4k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 6,727 shares
@ $21.09, valued at
$141.9k
|
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 6,516 shares
@ $42.14, valued at
$274.6k
Sold 59,418 shares
@ $40.77, valued at
$2.4M
Sold 11,551 shares
@ $38.65, valued at
$446.4k
Exercised 59,418 options to buy
@ $18.45, valued at
$1.1M
|
|
| 08/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Sold 3,059 shares
@ $27.93, valued at
$85.4k
|
|
| 02/23/2021 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 3,072 shares
@ $28.69, valued at
$88.1k
Sold 19,769 shares
@ $28.62, valued at
$565.8k
Exercised 19,769 options to buy
@ $17.67, valued at
$349.3k
|
|
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Sold 25,495 shares
@ $17.36, valued at
$442.6k
|
|
| 05/19/2020 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Paid exercise price by delivering 13,790 shares
@ $17.86, valued at
$246.3k
|
|
| 02/25/2020 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 24,524 shares
@ $0
Granted 79,075 options to buy
@ $17.67, valued at
$1.4M
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2019 |
4
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 157,143 shares
@ $0 |
|
| 05/16/2019 |
3
| Brophy Gerard (EVP, Biopharma Production) has filed a Form 3 on Avantor, Inc. |
|
|